首页> 外文期刊>Transfusion medicine >Effective transfusion audit can improve and alter clinical practice: something that is often questioned.
【24h】

Effective transfusion audit can improve and alter clinical practice: something that is often questioned.

机译:有效的输血审核可以改善和改变临床实践:这经常被质疑。

获取原文
获取原文并翻译 | 示例
           

摘要

In 2000, use of fresh frozen plasma (FFP) within the West of Scotland (WoS) was rising at 2% per annum. Published studies suggested that most indications for FFP use were thought to be inappropriate (Thomson et al., 1991; Jones et al., 1998). As a result, a regional audit to determine FFP and cryoprecipitate (cryo) use was carried out in 2000 under the direction of the West of Scotland Consultant Haematologists' Audit Group and results published in this journal (Soutar et al., 2004). This group encompasses the area supported by the WoS Regional Transfusion Centre, a population of approximately 3 million serviced by 15 hospitals. The main findings of this study were disproportionate use of FFP in tertiary centres (by a factor of almost 2) compared with district hospitals, and indications for use of FFP were out with British Committee for Standards in Haematology (BCSH) guidelines in 32% of issues. This initial study stimulated a local practice review in outlying hospitals to address their transfusion practices, and it was also suggested that each hospital develop its own protocol for FFP and cryo replacement. We set out to re-audit blood product use and practice within the WoS to assess the impact of the first audit. Unfortunately, because of the time-consuming nature of the second-stage examining indications for FFP use, this was not repeated during this audit cycle.
机译:2000年,苏格兰西部(WoS)的新鲜冷冻血浆(FFP)的使用量以每年2%的速度增长。已发表的研究表明,大多数使用FFP的适应症被认为是不合适的(Thomson等,1991; Jones等,1998)。结果,在苏格兰西部顾问血液学家审核小组的指导下,于2000年进行了确定FFP和冷冻沉淀(冷冻)用途的区域审核,结果发表在了该期刊上(Soutar等,2004)。该群体涵盖了由WoS地区输血中心支持的区域,该区域有15所医院为大约300万人提供服务。这项研究的主要发现是,与地区医院相比,三级医院使用FFP的比例不成比例(几乎是2倍),而英国血液学标准委员会(BCSH)指南中指出使用FFP的指征是32%问题。这项最初的研究激发了外围医院对当地实践的审查,以解决他们的输血实践,并且还建议每家医院针对FFP和冷冻替代品制定自己的协议。我们着手对WoS中的血液产品使用和实践进行重新审核,以评估首次审核的影响。不幸的是,由于使用FFP的第二阶段检查指示耗时,因此在此审核周期中没有重复进行。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号